Search results
Ken Anderson, MD, gives a comprehensive update on research and treatment of multiple myeloma, including new advances presented at the American Society of Hematology Annual Meeting in 2023.
Dr. Ken Anderson is the Kraft Family Professor of Medicine at Harvard Medical School, as well as Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute.
Dr. Anderson is the Kraft Family Professor of Medicine at Harvard Medical School as well as Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute.
Nov 29, 2012 · Making Science Count: A Conversation with Ken Anderson. When Ken Anderson, MD, began working on multiple myeloma four decades ago, the disease, a cancer of the bone marrow, was untreatable. “People died within months,” says Anderson. Today, the story is very different.
- Dana-Farber
Dr. Kenneth Anderson is the Kraft Family Professor of Medicine at Harvard Medical School, as well as Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute.
Unraveled is a podcast produced by Dana-Farber that explores the mysteries of the science of cancer. Veteran broadcaster Ken Shulman digs into the cutting-edge science that is transforming cancer research and providing hope for scientists and cancer patients.
Kenneth Anderson, MD is the Kraft Family Professor of Medicine at Harvard Medical School as well as Director of the Jerome Lipper Multiple Myeloma Center and Lebow Institute for Myeloma Therapeutics at Dana-Farber Cancer Institute.
